LXS196

Darovasertib (LXS196) is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 μM for PKCα, PKCθ and GSK3β, respectively. Darovasertib has the potential for uveal melanoma research.


Cat. No.: EX-A2690	Purity: >98%

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	438	In-stock
250mg	650	In-stock
500mg	985	In-stock
1g	1385	In-stock
5g	3885	In-stock
10g	5800	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	IDE196
Synonyms 2	Darovasertib
CAS No.	1874276-76-2
Purity	>98%
Formula	C22H23F3N8O
Mol Weight	472.4662
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Protein Kinase C Inhibitor LXS196 [2]. US20180179181.
CoA	CoA of LXS196

Smiles:	CC1(N)CCN(CC1)C1=C(NC(=O)C2=C(N)N=CC(=N2)C2=NC=CC=C2C(F)(F)F)N=CC=C1


		Search